
National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 5)
National Health Act 1953
___________________________________________________________________________
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 29 June 2020
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
_________________________________________________________________________
1 Name of Instrument
(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 5).
(2) This Instrument may also be cited as PB 62 of 2020.
2 Commencement
This Instrument commences on 1 July 2020.
3 Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
[1] Schedule 1, entry for Clonazepam
Omit:
Clonazepam | Tablet 2 mg | Oral | Rivotril | 100 | 9.96 | 12.10 |
| Tablet 500 mcg | Oral | Rivotril | 50 | 2.65 | 3.51 |
|
|
|
| 100 |
| 7.01 |
Substitute:
Clonazepam | Tablet 500 mcg | Oral | Rivotril | 50 | 2.65 | 3.51 |